Multivalent pneumococcal polysaccharide-protein conjugate composition
US9981029B2 · kind B2 · utility
7Cited by
26References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 2013 |
| Grant date | May 29, 2018 |
| Priority date | — |
| Expiry date | Jan 6, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is an immunogenic composition comprising 13 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from a different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, 12 serotypes selected from the group consisting of 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F and serotype 2 or 9N. The immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases coverage with respect to pneumococcal diseases in infants and children.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.